<code id='C021D88CAB'></code><style id='C021D88CAB'></style>
    • <acronym id='C021D88CAB'></acronym>
      <center id='C021D88CAB'><center id='C021D88CAB'><tfoot id='C021D88CAB'></tfoot></center><abbr id='C021D88CAB'><dir id='C021D88CAB'><tfoot id='C021D88CAB'></tfoot><noframes id='C021D88CAB'>

    • <optgroup id='C021D88CAB'><strike id='C021D88CAB'><sup id='C021D88CAB'></sup></strike><code id='C021D88CAB'></code></optgroup>
        1. <b id='C021D88CAB'><label id='C021D88CAB'><select id='C021D88CAB'><dt id='C021D88CAB'><span id='C021D88CAB'></span></dt></select></label></b><u id='C021D88CAB'></u>
          <i id='C021D88CAB'><strike id='C021D88CAB'><tt id='C021D88CAB'><pre id='C021D88CAB'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:74
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Biotech startup Celsius cuts 75% of staff ahead of first trial start
          Biotech startup Celsius cuts 75% of staff ahead of first trial start

          AdobeLaunchingyourfirstclinicaltrialisthetypeofannouncementmostbiotechexecutiveseagerlyanticipate,ho

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          Alnylam reports growth in sales of rare disease treatments

          KristofferTripplaar/SipaUSA/APAlnylamPharmaceuticalssaidThursdaythatsalesofitstreatmentsforraredisea